Market Tracker

02/27 5:16pm ET

Innoviva Inc (NASDAQ:INVA)

11.90
Delayed Data
As of Feb 27
 +0.42 / +3.66%
Today’s Change
8.67
Today|||52-Week Range
14.15
+11.21%
Year-to-Date
Can The Uptrend Continue for Innoviva (INVA)?
Feb 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close11.48
Today’s open11.49
Day’s range11.41 - 11.90
Volume884,185
Average volume (3 months)932,657
Market cap$1.2B
Dividend yield8.41%
Data as of 4:00pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+142.77%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+97.09%
P/E ratio34.0
Price/Sales9.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+1.35+5.34%
EBSEmergent BioSolution...+0.68+2.27%
FWPForward Pharma A/S-0.46-1.64%
DERMDermira Inc+0.98+2.95%
Data as of 4:02pm ET, 02/27/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$0.26
Annual revenue (last year)$133.6M
Annual profit (last year)$59.5M
Net profit margin44.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts